Endovia Health Sciences (SBEV) executive compensation, 2025 proxy

Robert Nistico, CEO, was paid $734,619 in 2024, up 111% from $347,525 the year before.

Filed
October 6, 2025
Annual meeting
October 31, 2025
Pay year
2024
Named executives
3
CEO total pay
$734,619+111% vs prior year
President option awards
$247,500
CFO option awards
$247,500
CFO signing bonus
$60,000Under February 2025 agreement
CFO annual salary
$325,000Under February 2025 agreement
Director warrants
750,000Five-year warrants
CFO warrants
1,000,000Five-year warrants

How Nistico was paid

$734,619 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary44%Option awards54%All other compensation2%

Named executive officers

ExecutiveTotal
Robert NisticoCEO$734,619
William MeissnerPresident and CMO$581,519
Julius IvancsitsCFO$460,780

What changed and why

  • $735K$734,619 CEO total compensation in 2024 included $396,000 of option awards and exceeded the 2023 total of $347,525.
  • $325K$324,819 CEO salary in 2024 was accompanied by $13,800 in perquisites and other benefits.
  • $248K$247,500 in option awards were reported for both the President and CMO and the CFO in 2024.
  • $325K$325,000 annual salary and $60,000 signing bonus were provided under the CFO's February 2025 employment agreement.
  • 750,000 five-year warrants were granted to each director, the CEO, and the President in August 2025.
  • 1,000,000 warrants were granted to the CFO in August 2025 with identical terms.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.